Pregnancy reduces RhoA/Rho kinase and protein kinase C signaling pathways downstream of thromboxane receptor activation in the rat uterine artery

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 302, Issue 12, 2012, Pages 2477-2488

  Goulopoulou, Styliani ^a   Hannan, Johanna L ^a   Matsumoto, Takayuki ^a,b   Webb, R Clinton ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b HOSHI UNIVERSITY   (Japan)

Author keywords

Gestation; Prostanoid receptor; Prostanoids; Thromboxane A2; Vascular reactivity

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; BISINDOLYLMALEIMIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE C; RHO KINASE; THROMBOXANE A2 RECEPTOR; THROMBOXANE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; EX VIVO STUDY; FEMALE; FORCE; MALE; MESENTERIC ARTERY; MYOGRAPHY; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; RAT; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION; UTERINE ARTERY; UTERINE BLOOD VESSEL; VASOCONSTRICTION;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; AMIDES; ANIMALS; ENZYME INHIBITORS; FEMALE; INDOLES; MALEIMIDES; MESENTERIC ARTERIES; PREGNANCY; PREGNANCY, ANIMAL; PROTEIN KINASE C; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, THROMBOXANE; RHO-ASSOCIATED KINASES; SIGNAL TRANSDUCTION; UTERINE ARTERY; UTERUS; VASOCONSTRICTOR AGENTS;

EID: 84862540969     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00900.2011     Document Type: Article

References (51)

1. Allahdadi KJ, Hannan JL, Ergul A, Tostes RC, Webb RC. Internal pudendal artery from type 2 diabetic female rats demonstrate elevated endothelin-1-mediated constriction. J Sex Med 8: 2472-2483, 2011.
2. Bolla M, Matrougui K, Loufrani L, Maclouf J, Levy B, Levy-Tole-dano S, Habib A, Henrion D. p38 mitogen-activated protein kinase activation is required for thromboxane- induced contraction in perfused and pressurized rat mesenteric resistance arteries. J Vasc Res 39: 353-360, 2002.
3. 2+ sensitization of rabbit myometrium during pregnancy-role of Rnd3. J Physiol 552: 403-413, 2003.
4. Chitaley K, Webb RC. Nitric oxide induces dilation of rat aorta via inhibition of rho-kinase signaling. Hypertension 39: 438-442, 2002.
5. Cipolla M, Osol G. Hypertrophic and hyperplastic effects of pregnancy on the rat uterine arterial wall. Am J Obstet Gynecol 171: 805-811, 1994.
6. Clark SL, Cotton DB, Lee W, Bishop C, Hill T, Southwick J, Pivarnik J, Spillman T, DeVore GR, Phelan J, et al. Central hemodynamic assessment of normal term pregnancy. Am J Obstet Gynecol 161: 1439-1442, 1989.
7. Cooke CL, Davidge ST. Pregnancy-induced alterations of vascular function in mouse mesenteric and uterine arteries. Biol Reprod 68: 1072-1077, 2003.
8. Devillier P, Bessard G. Thromboxane A2 and related prostaglandins in airways. Fundam Clin Pharmacol 11: 2-18, 1997.
9. Dorn GW, Liel N, Trask JL, Mais DE, Assey ME, Halushka PV. Increased platelet thromboxane A2/prostaglandin H2 receptors in patients with acute myocardial infarction. Circulation 81: 212-218, 1990.
10. 2+ homeostasis in human myometrial smooth muscle cells. Am J Physiol Cell Physiol 276: C379-C385, 1999.
11. Gao Y, Tang S, Zhou S, Ware JA. The thromboxane A2 receptor activates mitogen-activated protein kinase via protein kinase C-dependent Gi coupling and Src-dependent phosphorylation of the epidermal growth factor receptor. J Pharmacol Exp Ther 296: 426-433, 2001.
12. Giachini FR, Sullivan JC, Lima VV, Carneiro FS, Fortes ZB, Pollock DM, Carvalho MH, Webb RC, Tostes RC. Extracellular signal-regulated kinase 1/2 activation, via downregulation of mitogen-activated protein kinase phosphatase 1, mediates sex differences in desoxycorticosterone acetate-salt hypertension vascular reactivity. Hypertension 55: 172-179, 2010.
13. Gokina NI, Kuzina OY, Vance AM. Augmented EDHF signaling in rat uteroplacental vasculature during late pregnancy. Am J Physiol Heart Circ Physiol 299: H1642-H1652, 2010.
14. Gorenne I, Su X, Moreland RS. Inhibition of p42 and p44 MAP kinase does not alter smooth muscle contraction in swine carotid artery. Am J Physiol Heart Circ Physiol 275: H131-H138, 1998.
15. Han J, Lee JD, Bibbs L, Ulevitch RJ. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265: 808-811, 1994.
16. Hayashi M, Inoue T, Hoshimoto K, Hirabayashi H, Negishi H, Oh-kura T. The levels of five markers of hemostasis and endothelial status at different stages of normotensive pregnancy. Acta Obstet Gynecol Scand 81: 208-213, 2002.
17. Howarth SR, Vallance P, Wilson CA. Role of thromboxane A2 in the vasoconstrictor response to endothelin-1, angiotensin II and 5-hydroxy-tryptamine in human placental vessels. Placenta 16: 679-689, 1995.
18. Johnson RL, Gilbert M, Meschia G, Battaglia FC. Cardiac output distribution and uteroplacental blood flow in the pregnant rabbit: a comparative study. Am J Obstet Gynecol 151: 682-686, 1985.
19. Kanashiro CA, Cockrell KL, Alexander BT, Granger JP, Khalil RA. Pregnancy-associated reduction in vascular protein kinase C activity rebounds during inhibition of NO synthesis. Am J Physiol Regul Integr Comp Physiol 278: R295-R303, 2000.
20. Katoue MG, Khan I, Oriowo MA. Pregnancy-induced modulation of calcium mobilization and down-regulation of Rho-kinase expression contribute to attenuated vasopressin-induced contraction of the rat aorta. Vascul Pharmacol 44: 170-176, 2006.
21. 2+ sensitization of contractile elements in rat myometrium. Biochem Biophys Res Commun 311: 972-978, 2003.
22. Kriston T, Venuto RC, Baylis C, Losonczy G. Hemodynamic and renal effects of U-46619, a TXA2/PGH2 analog, in late-pregnant rats. Am J Physiol Regul Integr Comp Physiol 276: R831-R837, 1999.
23. Kutz C, Paintz M, Glusa E. Inhibition of thrombin-induced contractile responses by protein kinase inhibitors in porcine pulmonary arteries. Exp Toxicol Pathol 50: 497-500, 1998.
24. Li M, Kuo L, Stallone JN. Estrogen potentiates constrictor prostanoid function in female rat aorta by upregulation of cyclooxygenase-2 and thromboxane pathway expression. Am J Physiol Heart Circ Physiol 294: H2444-H2455, 2008.
25. Li M, Stallone JN. Estrogen potentiates vasopressin-induced contraction of female rat aorta by enhancing cyclooxygenase-2 and thromboxane function. Am J Physiol Heart Circ Physiol 289: H1542-H1550, 2005.
26. Losonczy G, Brown G, Mucha I, Klocke R, Muller V, Merkely B, Tornoci L, Rosivall L, Venuto R. Gestational resistance to the pulmonary vasoconstrictor effect of the TxA2 mimetic U-46619: possible mechanism. Am J Physiol Regul Integr Comp Physiol 272: R1734-R1739, 1997.
27. Losonczy G, Singh JP, Schoenl M, Mucha I, Venuto RC. Pregnancy enhances the pressor response to thromboxane analogues in rabbits. Am J Physiol Regul Integr Comp Physiol 269: R720-R725, 1995.
28. Matrougui K, Tanko LB, Loufrani L, Gorny D, Levy BI, Tedgui A, Henrion D. Involvement of Rho-kinase and the actin filament network in angiotensin II-induced contraction and extracellular signal-regulated kinase activity in intact rat mesenteric resistance arteries. Arterioscler Thromb Vasc Biol 21: 1288-1293, 2001.
29. Matsumoto T, Kobayashi T, Ishida K, Taguchi K, Kamata K. Enhancement of mesenteric artery contraction to 5-HT depends on Rho kinase and Src kinase pathways in the ob/ob mouse model of type 2 diabetes. Br J Pharmacol 160: 1092-1104, 2010.
30. Meagher EA, FitzGerald GA. Disordered eicosanoid formation in pregnancy-induced hypertension. Circulation 88: 1324-1333, 1993.
31. Meloche S, Landry J, Huot J, Houle F, Marceau F, Giasson E. p38 MAP kinase pathway regulates angiotensin II-induced contraction of rat vascular smooth muscle. Am J Physiol Heart Circ Physiol 279: H741-H751, 2000.
32. Miggin SM, Kinsella BT. Regulation of extracellular signal-regulated kinase cascades by alpha- and beta-isoforms of the human thromboxane A2 receptor. Mol Pharmacol 61: 817-831, 2002.
33. Nakahata N. Thromboxane A2: physiology/pathophysiology, cellular signal transduction and pharmacology. Pharmacol Ther 118:18-35, 2008.
34. Narumiya S, Sugimoto Y, Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol Rev 79: 1193-1226, 1999.
35. Nelson SH, Steinsland OS, Johnson RL, Suresh MS, Gifford A, Ehardt JS. Pregnancy-induced alterations of neurogenic constriction and dilation of human uterine artery. Am J Physiol Heart Circ Physiol 268: H1694-H1701, 1995.
36. Ohanian J, Cunliffe P, Ceppi E, Alder A, Heerkens E, Ohanian V. Activation of p38 mitogen-activated protein kinases by endothelin and noradrenaline in small arteries, regulation by calcium influx and tyrosine kinases, and their role in contraction. Arterioscler Thromb Vasc Biol 21: 1921-1927, 2001.
37. Perneby C, Vahter M, Akesson A, Bremme K, Hjemdahl P. Thromboxane metabolite excretion during pregnancy-influence of preeclampsia and aspirin treatment. Thromb Res 127: 605-606, 2011.
38. 2+ sensitization of contraction in vascular smooth muscle. J Biol Chem 275: 21722-21729, 2000.
39. Sibai BM, Frangieh A. Maternal adaptation to pregnancy. Curr Opin Obstet Gynecol 7: 420-426, 1995.
40. Stirling Y, Woolf L, North WR, Seghatchian MJ, Meade TW. Haemostasis in normal pregnancy. Thromb Haemost 52: 176-182, 1984.
41. Ungvari Z, Brown G, Venuto R, Koller A, Losonczy G. Increased NO-mediated and reduced TxA2-dependent responses in skeletal muscle arterioles in pregnancy. Hypertens Pregnancy 21: 135-146, 2002.
42. Wareing M, O'Hara M, Seghier F, Baker PN, Taggart MJ. The involvement of Rho-associated kinases in agonist-dependent contractions of human maternal and placental arteries at term gestation. Am J Obstet Gynecol 193: 815-824, 2005.
43. Weiner CP, Thompson LP, Liu KZ, Herrig JE. Endothelium-derived relaxing factor and indomethacin-sensitive contracting factor alter arterial contractile responses to thromboxane during pregnancy. Am J Obstet Gynecol 166: 1171-1181, 1992.
44. Wight E, Kung CF, Moreau P, Takase H, Bersinger NA, Luscher TF. Aging, serum estradiol levels, and pregnancy differentially affect vascular reactivity of the rat uterine artery. J Soc Gynecol Investig 7: 106-113, 2000.
45. Wikstrom K, Kavanagh DJ, Reid HM, Kinsella BT. Differential regulation of RhoA-mediated signaling by the TPa and TP(3 isoforms of the human thromboxane A2 receptor: independent modulation of TPa signaling by prostacyclin and nitric oxide. Cell Signal 20: 1497-1512, 2008.
46. 2+ sensitization: Rho-associated kinasemediated phosphorylation of MYPT1 at Thr-855, but not Thr-697. Biochem J 389: 763-774, 2005.
47. Woods LL. Importance of prostaglandins in hypertension during reduced uteroplacental perfusion pressure. Am J Physiol Regul Integr Comp Physiol 257: R1558-R1561, 1989.
48. Xiao D, Liu Y, Pearce WJ, Zhang L. Endothelial nitric oxide release in isolated perfused ovine uterine arteries: effect of pregnancy. Eur J Pharmacol 367: 223-230, 1999.
49. 2+. Am J Physiol Heart Circ Physiol 281: H183-H190, 2001.
50. Xiao D, Zhang L. ERK MAP kinases regulate smooth muscle contraction in ovine uterine artery: effect of pregnancy. Am J Physiol Heart Circ Physiol 282: H292-H300, 2002.
51. Zhang H, Xiao D, Longo LD, Zhang L. Regulation of a1-adrenoceptor-mediated contractions of uterine arteries by PKC: effect of pregnancy. Am J Physiol Heart Circ Physiol 291: H2282-H2289, 2006.